Pharmaceuticals and healthcare


moves, lateral hires and exits

Norton Rose hit with mass defection as 15-strong team exit to Reed Smith

A team of 15 lawyers across four different Norton Rose Fulbright offices in the US have decamped to join Reed Smith. The team includes global head of life sciences and healthcare Rick Robinson, Washington partner Lesley Reynolds, Austin partners Jeff Layne and Ben Koplin and New York partner Cori Goldberg. Two Norton Rose associates, Washington […]

Daniel Brook, pharma litigation, Hogan Lovells

Brook, Daniel – Hogan Lovells

As a former chemistry student, Hogan Lovells IP partner Daniel Brook has honed his legal and science knowledge to become indispensable to several of the world’s largest pharmaceutical companies looking to safeguard their products. One of the most important judgments last year was Eli Lilly’s landmark patent trial against pharmaceutical rival Actavis. Brook took the […]



Clifford Chance secures victory over Cleary in landmark Google dispute

Cleary Gottlieb Steen & Hamilton-represented Google has been hit with a record £3.8bn (€4.3bn) fine by the European Union Commission (EC) for breaching EU antitrust rules. This is the second record EC antitrust fine that Google has been hit with in two years, following a £2.1bn (€2.4bn) fine in 2017, both of which were pursued […]


Clydes recruits new CIO to review tech strategy

Clyde & Co has appointed a new chief information officer to spearhead the firm’s data and IT strategy, after the departure of former lead Chris White. White joined Clydes in June 2013, but turned his 18-month initial contract into a full-time role in December 2015 to adequately implement his plans for the firm. He said: “After […]


Clydes leads as Cheesegrater 2 gets go-ahead

Clyde & Co is advising Hong-Kong based developers Lai Sun Development Company in the construction of 100 Leadenhall – a skyscraper that is set to be London’s third tallest tower. Real estate partner Martin Quicke, who specialises in advising property companies and overseas investors from Hong Kong and South east Asia, is leading for Lai […]


Clifford Chance to streamline use of chambers in litigation shake-up

Clifford Chance is set to reduce the number of chambers it instructs, after an internal survey of its litigation practice revealed it was instructing too many individual sets. The Lawyer understands that senior management at the magic circle firm surveyed the entire practice to better understand the range of sets that were being instructed. A […]


Ince cuts 32 roles in London in latest redundancy consultation

Ince & Co‘s redundancy consultation has resulted in the departure of 32 people and a search to sub-let 22 per cent of the firm’s floor space in its London headquarters. Of those 32, 25 business services staff have now left the firm along with a further seven fee-earners, including one junior salaried partner. There are […]

Kevin Gold

Mishcon posts 8% rise in turnover as firm breaks £160m

An 8 per cent increase in turnover at Mishcon de Reya last year saw the firm break through the £160m barrier for the first time in its history, posting £161.3m for the 2017/18 financial year. The increase in the firm’s top line means it has now added more than £30m in revenue growth in the […]

Gateley posts third consecutive year of double-digit growth since IPO

Gateley’s revenue has increased by 11 per cent from £77.6m to £86.1m in its third full year as a listed entity. The firm posted double-digit rises across the board for 2017/2018, with profit before tax increasing by nearly 12 per cent from £13.1m in 2016/2017 to £14.6m. Adjusted earnings before interest and tax (EBITDA) saw a […]

High Court

Pinsents slammed for “shameful” treatment of defendants in Aeroflot case

A High Court judge has slammed Pinsent Masons for its actions following the death of Russian oligarch Nikolay Glushkov, accusing the firm of having lost “sight of any basic standard of decent and compassionate behaviour” in a long-running case brought by Russian airline Aeroflot. The litigation centered around allegations made against, among others, the late Russian oligarch […]


Freshfields and Paul Hastings lead on €260m telecoms sale

Freshfields Bruckhaus Deringer and Paul Hastings have picked up lead roles on the latest bumper deal in the increasingly active telecoms sector. The magic circle firm has been advising South African company MTN Group on its sale of subsidiary company MTN Cyprus to Monaco Telecom for approximately €260m. Paul Hastings is representing the buyer Monaco […]

Featured Briefings

Russian patents: Rospatent fee-based extradited examination

By Maria Aronikova On October 5 2017 the Russian Patent and Trademark Office (Rospatent) officially announced that expedited examination will be available for all applications. Rospatent had abrogated its former expedited examination practice in 2012. Since then, patent law has allowed accelerated examination through the Patent Prosecution Highway (PPH) system…

Sleeping time is not working time says Court of Appeal

By Siobhan Fitzgerald The social care sector is breathing a sigh of relief after the Court of Appeal in Royal Mencap Society v Tomlinson-Blake reversed previous cases and decided that only time spent awake and working should be counted as working time for the purposes of calculating the national minimum wage.

Amendment of the Code of Conduct for Pharmaceutical Advertising

The Code of Conduct for Pharmaceutical Advertising (Code of Conduct) (In Dutch: Gedragscode Geneesmiddelenreclame) has been amended as of 1 July, 2018. The changes come as a response to the amendments to the policy rules providing guidance on the ban of inducements regarding medicinal products, which entered into force 1 April, 2018 (Policy Rules) (In Dutch: Beleidsregels gunstbetoon Geneesmiddelenwet […]

Amendment of the code of conduct for pharmaceutical advertising

The Code of Conduct for Pharmaceutical Advertising (Code of Conduct) (In Dutch: Gedragscode Geneesmiddelenreclame) has been amended as of 1 July, 2018. The changes come as a response to the amendments to the policy rules providing guidance on the ban of inducements regarding medicinal products, which entered into force 1 April, 2018 (Policy Rules) (In Dutch: Beleidsregels gunstbetoon Geneesmiddelenwet […]

Material contribution in acute hypoxic ischaemia

By John de Bono QC There is no doubt that since the decision in Bailey v MoD the claimant’s task in proving causation has become significantly easier because she no longer needs to prove that her condition is worse than it would have been ‘but for’ the defendant’s breach of duty. There are cases where […]

‘Bolam is dead, long live Bolam’

By Dr Simon Fox QC As a doctor transferring from medicine to law 25 years ago, I was struck by the illogicality of the Bolam test, in that it seemed to me that it couldn’t logically be applied to many circumstances of medical negligence…

Shire successfully defends Canadian VYVANSE patent

By Alexander Camenzind Apotex’s invalidity allegations regarding Shire’s Canadian Patent 2,527,646 covering the active ingredient in Shire’s ADHD medication VYVANSE® have been rejected following a 17­day trial before Justice Fothergill of the Federal Court.[1] Fothergill J. held that each of the claims in issue of the 646 Patent are not invalid on any of the […]

European food law update – Meyer’s newsletter, July 2018

Loyens & Loeff’s food and beverages team was invited to contribute once more to Meyer’s newsletter on recent legal and regulatory developments on European food law, with a special focus for this edition on health claims. This newsletter gathers contributions for a large panel of European countries, include three of our home markets…

Ireland joins international collaboration on drug pricing and supply

On 22 June 2018, the Irish Minister for Health has signed an Agreement to join the BeNeLuxA initiative on pharmaceutical policy. In 2015 the BeNeLuxA cooperation was initiated by the Netherlands and Belgium. Since then, Luxembourg joined the cooperation followed by Austria. The BeNeLuxA initiative aims for sustainable access to, and appropriate use of, medicines […]

How to shoot for Arrow relief

By Paul Inman and Christopher Freeth The Court of Appeal has ruled that the discretion as to whether or not to award Arrow relief lies with the trial judge, for exercise in light of the facts and circumstances at the date of the trial. In an application to strike out such a claim (i.e. before the […]

New mandatory breach reporting under the Alberta Health Information Act

By Krista Schofer Alberta’s Health Information Act (HIA) outlines the rules for the collection, use and disclosure of health information that is in the custody or under the control of a “custodian” — a defined term in the HIA, which includes Alberta Health Services and health professionals such as physicians and dentists who are regulated […]

Investigative powers under Alberta’s new OHS Act

By Maxell Brunette, Alison Gray and Bruce Graham On June 1, 2018, amendments to Alberta’s Occupational Health and Safety Act (the “New Act”) came into force, significantly expanding the nature of the health and safety obligations owed by employers and businesses in Alberta. This article focuses on one of the areas in which changes have […]

Register now to The Lawyer to access our latest news stories, read selected briefings from key firms and gain essential careers insight to help you make the most of your current and future roles.

Contact Us: if you have any questions regarding your subscription, call us on +44 (0)20 7292 3716 or email us at

Register now

Having problems?

Contact us on +44 (0)20 7292 3716 | email:

If you are looking for our Jobs site, please click here